Philadelphia-based Cabaletta Bio, a late-stage clinical biotechnology company, and California-based Cellares, a company ...

Red blood cells modified with Nobel-prizewinning chemistry can snap together to form clots that staunch bleeding in seconds. That’s according to a study, published on 29 April in Nature 1, that tested ...

Scientists have discovered how cells decide when to respond to physical forces, potentially opening new avenues for tackling ...

AI could "give the scientific community a way to address the most difficult and urgent questions in human health," argues ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA ...

A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments.

A key molecular dynamic could be the key to fighting tumors while allowing patients to still receive life-saving cell ...

In tissue engineering, the tiniest bit of improper force can harm a living culture. Spheroids—3D clumps of cells—can be used ...

Ultrasome™ Demonstrates Strong Clinical Signal While Leveraging GMP-Produced CELZ-201 (Olastrocel) to Target Large, Underserved Osteoarthritis ...

Bloom Energy (BE) stock catapulted higher on Tuesday on AI data center demand for the company’s solid oxide fuel cell technology. Bloom Energy delivered Q4 revenue of $777.68M (+36% YoY), beating ...

Astellas is preparing to close its Seattle site for its stem cell therapy unit, with around 55 employees set to be affected. The Japanese pharma acquired the site when it bought Seattle-based ...

Reliance Industries Ltd has become the first company to secure inclusion of heterojunction (HJT) solar cells in the Approved List of Models and Manufacturers (ALMM) issued by India’s Ministry of New ...